Picture of NewAmsterdam Pharma logo

NAMS — NewAmsterdam Pharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Brief: Newamsterdam Pharma Company NV Announces Appointment Of David Topper As Chief Financial Officer

Dec 19 (Reuters) - NewAmsterdam Pharma Company NV
 NAMS.O :
    * NEWAMSTERDAM ANNOUNCES APPOINTMENT OF DAVID TOPPER AS
CHIEF
FINANCIAL OFFICER
    * NEWAMSTERDAM PHARMA COMPANY NV - ANNOUNCED APPOINTMENT OF
DAVID
TOPPER AS CHIEF FINANCIAL OFFICER ("CFO"), EFFECTIVE JANUARY 1,
2023
    * NEWAMSTERDAM PHARMA COMPANY NV - DAVID TOPPER SUCCEEDS
LOUISE
KOOIJ, WHO WILL TRANSITION TO ROLE OF CHIEF ACCOUNTING OFFICER

Source text for Eikon:  ID:nGNX2np0ct 
Further company coverage:  NAMS.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on NewAmsterdam Pharma

See all news